| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 02/20/2008 | EP1383747B1 Fused pyrimidines as antagonists of the corticotropin releasing factor (crf) |
| 02/20/2008 | EP1225915B1 Use of anti-il-2 polyclonal antibodies for the treatment of insulin-dependent diabetes mellitus and lupus erythematosus |
| 02/20/2008 | CN101128431A Novel quinoline derivatives as potassium ion channel openers |
| 02/20/2008 | CN101128201A Use of a pyrazole derivative for preparing medicines useful for preventing or treating renal diseases |
| 02/20/2008 | CN101125191A Traditional Chinese medicine composition for curing non-gonococcal urethritis |
| 02/20/2008 | CN101125189A Traditional Chinese medicine for curing kidney disease and its preparation method |
| 02/20/2008 | CN101125186A Chinese medicine for treating prostatitis |
| 02/20/2008 | CN101125137A Pharmaceutical salts |
| 02/20/2008 | CN101125134A Hydrochloric tamsulosin sustained-release capsule and its preparation method |
| 02/20/2008 | CN101124993A Production method of health-care food for lithiasis patient |
| 02/20/2008 | CN100369931C Monoclonal antibody against human B7-1 molecule and its use |
| 02/20/2008 | CN100369919C Tricyclic protein kinase inhibitors |
| 02/20/2008 | CN100369917C Himbacine analogues as thrombin receptor antagonists |
| 02/20/2008 | CN100369898C Nicotinamide derivates useful as p38 inhibitors |
| 02/20/2008 | CN100369894C Nitric oxide synthase inhibitor phosphate salt |
| 02/19/2008 | US7332579 Antiproliferative agents; anticancer agents |
| 02/19/2008 | US7332517 1-(1H-indol-3-ylmethyl)-3-(4-nitrophenyl)-5-[2-(4-phenyl-1H-imidazol-2-yl)ethyl]-2thioxo-4imidazolidinone; somastatin receptor affinity; acromegaly, hypophyseal adenomas, endocrine gastroenteropancreatic tumors, as carcinoid syndrome and gastrointestinal bleeding |
| 02/19/2008 | US7332497 Pyrazolopyrimidines as therapeutic agents |
| 02/19/2008 | US7332473 derived from a PACAP or VIP peptide; can inhibit tautomerization in a solution; regressive neurodegenerative diseases, erectile dysfunction, and bronchial asthma; inhibited isomerization and high stability during the production and storage |
| 02/19/2008 | US7332301 Insulin-like growth factor binding protein |
| 02/19/2008 | US7332185 Component I selected from alpha acids and beta acids and component II selected from alpha acids, beta acids, essential oils, fats and waxes; specific inhibition of cyclooxygenase-2 with little effect on cyclooxygenase-1 |
| 02/19/2008 | CA2481723C 5ht2c receptor modulators |
| 02/19/2008 | CA2304698C Endothelin antagonist and beta receptor blocking agent as combined preparations |
| 02/19/2008 | CA2267668C Method for enhancing the efficiency of gene transfer with stem cell factor polypeptide |
| 02/19/2008 | CA2173976C Phenylacetate and derivatives alone or in combination with other compounds against neoplastic conditions and other disorders |
| 02/14/2008 | WO2008018827A1 Benzimidazole derivatives useful in treatment of vallinoid receptor trpv1 related disorders |
| 02/14/2008 | WO2008018544A1 Sulfonamide compound or salt thereof |
| 02/14/2008 | WO2008018450A1 Cell preparation containing multipotential stem cells originating in fat tissue |
| 02/14/2008 | WO2008018447A1 Aminoalcohol derivative and immunosuppressant containing the same as active ingredient |
| 02/14/2008 | WO2008018427A1 Aminophosphoric acid ester derivative and s1p receptor modulator containing the same as active ingredient |
| 02/14/2008 | WO2008018306A1 Quinazoline derivative |
| 02/14/2008 | WO2008018111A2 Composition containing cranberry (vaccinium macrocarpon) and lactoferrin for the prevention and treatment of urinary tract infections |
| 02/14/2008 | WO2008017886A1 Novel hydrate form of o-desmethyl venlafaxine succinate |
| 02/14/2008 | WO2008017824A1 Bicyclo [2. 2. 1] hept-7-ylamine derivatives and their use |
| 02/14/2008 | WO2007018248A9 Pyridone compound |
| 02/14/2008 | US20080039516 Composition of Solifenacin or Salt Thereof for Use in Solid Formulation |
| 02/14/2008 | US20080039506 Aminoalcohol Derivatives |
| 02/14/2008 | US20080039488 Salt of naphthyridine carboxylic acid derivative |
| 02/14/2008 | US20080039454 Urotensin II receptor antagonists |
| 02/14/2008 | US20080039449 [1,4]benzodiazepine derivatives, used for treating osteoarthritis, pancreatitis, glomerulonephritis, rheumatoid arthritis, inflammatory bowel disease, Crohn's disease, psoriasis, graft vs host disease, leukemia, septic shock, multiple sclerosis, and inflammatory bowel disease |
| 02/14/2008 | US20080039447 CDK-Inhibitory pyrimidines, their production and use as pharmaceutical agents |
| 02/14/2008 | US20080039434 Treatment of Interstitial Cystitis with Vitamin D Compounds |
| 02/14/2008 | US20080039364 Modulating serum amyloid a interaction with tanis and agents useful for same |
| 02/14/2008 | US20080038365 TRPC6 involved in glomerulonephritis |
| 02/14/2008 | US20080038310 Coating comprising an elastin-based copolymer |
| 02/14/2008 | US20080038305 Ceramic Bulking Agent |
| 02/14/2008 | US20080038269 Methods for detecting and treating kidney disease |
| 02/14/2008 | US20080038264 Compositions and methods for the treatment of immune related diseases |
| 02/14/2008 | US20080038242 sodium-dependent nucleoside transporter 2 inhibitors; for diseases associated with abnormal plasma uric acid levels such as gout, hyperuricemia, urinary lithiasis, hyperuriciemic nephropathy, and acute uric acid nephropathy |
| 02/14/2008 | DE202007001170U1 Zusammensetzung, insbesondere für das Blockieren von Kathetern Composition, in particular for blocking catheters |
| 02/14/2008 | CA2660424A1 Sulfonamide compound or salt thereof |
| 02/14/2008 | CA2659967A1 Quinazoline derivatives |
| 02/14/2008 | CA2659599A1 Amino alcohol derivative and immunosuppressive agent having same as an active ingredient |
| 02/14/2008 | CA2659598A1 Amino phosphate derivative and s1p receptor modulator having same as an active ingredient |
| 02/14/2008 | CA2659295A1 Novel hydrate form of o-desmethyl venlafaxine succinate |
| 02/13/2008 | EP1887082A2 TADG-15: An extracellular serine protease overexpressed in carcinomas |
| 02/13/2008 | EP1887015A2 Method for extracting and using new human defence agents and biologically active proteins for treating infections and other illnesses |
| 02/13/2008 | EP1887008A1 Thienotriazolodiazepine compound and a medicinal use thereof |
| 02/13/2008 | EP1887000A1 Arylacetate derivative having isoxazole skeleton |
| 02/13/2008 | EP1886689A1 Oxidative stress inhibitor |
| 02/13/2008 | EP1886681A2 New nuclear transcription factors regulators |
| 02/13/2008 | EP1885348A2 Antipyretic agents against vr1-antagonist-induced increases in body temperature |
| 02/13/2008 | EP1517679B1 Ortho-substituted benzoic acid derivatives for the treatment of insulin resistance |
| 02/13/2008 | EP1480973B1 1,4-disubstituted benzofused cycloalkyl urea compounds useful in treating cytokine mediated diseases |
| 02/13/2008 | EP1463716B1 Pyrrolidine and piperidine derivates as nk1 antagonists |
| 02/13/2008 | EP1437944B1 Process for the fractionation of oilseed press cakes and meals |
| 02/13/2008 | EP1404650B1 Carboxamide-substituted phenylurea derivatives and method for production thereof as medicaments |
| 02/13/2008 | EP1289507B1 Use of an aldosterone antagonist for the treatment or prophylaxis of aldosterone-mediated pathogenic effects |
| 02/13/2008 | CN101124249A Human monoclonal antibodies to prostate specific membrane antigen(PSMA) |
| 02/13/2008 | CN101124197A Substantially pure tolterodine tartrate and process for preparing thereof |
| 02/13/2008 | CN101121740A Technique for preparing verbascoside with function of curing chronic glomerulonephritis in glutinous rehmannia leaf |
| 02/13/2008 | CN101120917A Compound amino acid injection composition suitable for kidney disease patient |
| 02/13/2008 | CN101120796A Method for making medicinal lilac duck |
| 02/13/2008 | CN101120785A Convenient food for auxiliary treating and preventing prostate diseases |
| 02/13/2008 | CN100368413C Composition stable blood porphrin derivative, its preparation method and injection agent |
| 02/13/2008 | CN100368411C 7-azaindoles as inhibitors of c-Jun N-terminal kinases for the treatment of neurodegenerative disorders |
| 02/13/2008 | CN100368394C N-(2-aryl-propionyl)-sulfonamides and pharmaceutical preparations containing them |
| 02/13/2008 | CN100367946C Gabapentin analogues for fibromy algia and other disorders |
| 02/13/2008 | CN100367944C Allicin microcapsule and its preparation method |
| 02/13/2008 | CN100367942C Bicarbonate-based solutions for dialysis therapies |
| 02/13/2008 | CN100367936C Oral drop pill in use for clearing sway heat and toxic material, relieving inflammation and dysentery, and preparation method |
| 02/13/2008 | CN100367928C Chinese materia medica preparation for treating hyperplasia of prostate and preparation method |
| 02/13/2008 | CN100367866C Method for preparing kidney-warming face-beautifying soybean milk powder with micron pine pollen, deer placenta powder, glossy privet fruit powder, white fungus powder and safflower powder |
| 02/13/2008 | CN100367863C Method for preparing kidney-warming face-beautifying yoghourt with micron pine pollen, deer placenta powder, glossy privet fruit powder, white fungus powder and safflower powder |
| 02/12/2008 | US7329782 Compounds for the treatment of metabolic disorders |
| 02/12/2008 | US7329777 Methods for treating heart failure, thromboembolic disorders, and pulmonary fibrosis |
| 02/12/2008 | US7329753 Quinoline and isoquinoline derivatives, a process for their production and their use as inflammation inhibitors |
| 02/12/2008 | US7329729 Secreted epithelial colon stromal-1 molecules and uses thereof |
| 02/12/2008 | US7329684 Modulators of the receptor for advanced glycated end products and interact with its ligands; antiinflammatory, antidiabetic and antitumor agents; Alzheimer's disease, erectile dysfunction, metastasis; 2-[(1R)-2-(4-Benzyloxyphenyl)-1-amino-1-ethyl]-3-butyl-5-(3-diethylamino-1-propoxy)benzimidazole |
| 02/12/2008 | US7329683 Moderation of cortisol; non-insulin dependent diabetes; hypotensive agents; using a 1,2,4 triazole compound |
| 02/12/2008 | US7329665 Quinazolinone derivative |
| 02/12/2008 | US7329660 Phthalazine derivatives for treating inflammatory diseases |
| 02/12/2008 | US7329653 (4-cyclohexyl-phenyl)-(4H, 10H-3a,5,9-triaza-benzo[f]azulen-9-yl)-methanone; antidiuretic, anticoagulant, diabetes insipidus, nocturnal enuresis, nocturia, urinary incontinence, delay of urination, or bleeding |
| 02/12/2008 | CA2496623C Benzenesulfonate salts of 4-fluoro-2-cyanopyrrolidine derivatives |
| 02/12/2008 | CA2341063C Transdermally administered tolterodine as anti-muscarinic agent for the treatment of overactive bladder |
| 02/12/2008 | CA2267543C Use of sulodexide and of the medicines containing it in the treatment of the diabetic retinopathy |
| 02/07/2008 | WO2008016171A1 Prophylactic/therapeutic agent for renal dysfunction |
| 02/07/2008 | WO2008016132A1 Benzyl phenyl glucopyranoside derivative |
| 02/07/2008 | WO2008016118A1 Agent targeting dopamine receptor and screening method therefor |
| 02/07/2008 | WO2008015867A1 Method for activating and stabilizing dissolved hydrogen in water |